The Gene Therapy Market on a global scale was estimated at USD 2.4 Bn in 2024 and is poised to attain USD 13.6 Bn by 2034, with a projected CAGR of 19.05% between 2025 and 2034.
At its core, Gene Therapy pertains to landscape are expandingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by expanding need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gene Therapy Market Snapshot
Chapter 4. Global Gene Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Gene silencing
5.2.2. Cell replacement
5.2.3. Gene augmentation
5.2.4. Other therapies
Chapter 6. Market Segmentation 2: By Vector Estimates & Trend Analysis
6.1. By Vector & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Vector:
6.2.1. Viral vectors
6.2.2. Non-Viral vectors
Chapter 7. Market Segmentation 3: By Delivery method Estimates & Trend Analysis
7.1. By Delivery method & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Delivery method:
7.2.1. In Vivo
7.2.2. Ex Vivo
Chapter 8. Market Segmentation 4: By Route of administration Estimates & Trend Analysis
8.1. By Route of administration & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Route of administration:
8.2.1. Intravenous
8.2.2. Other routes of administration
Chapter 9. Market Segmentation 5: By Therapeutic Area Estimates & Trend Analysis
9.1. By Therapeutic Area & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
9.2.1. Neurology
9.2.2. Oncology
9.2.3. Hepatology
9.2.4. Other therapeutic areas
Chapter 10. Gene Therapy Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Gene Therapy Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
10.1.2. North America Gene Therapy Market revenue (US$ Million) estimates and forecasts By Vector, 2021-2034
10.1.3. North America Gene Therapy Market revenue (US$ Million) estimates and forecasts By Delivery method, 2021-2034
10.1.4. North America Gene Therapy Market revenue (US$ Million) estimates and forecasts By Route of administration, 2021-2034
10.1.5. North America Gene Therapy Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
10.1.6. North America Gene Therapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Gene Therapy Market revenue (US$ Million) By Type, 2021-2034
10.2.2. Europe Gene Therapy Market revenue (US$ Million) By Vector, 2021-2034
10.2.3. Europe Gene Therapy Market revenue (US$ Million) By Delivery method, 2021-2034
10.2.4. Europe Gene Therapy Market revenue (US$ Million) By Route of administration, 2021-2034
10.2.5. Europe Gene Therapy Market revenue (US$ Million) By Therapeutic Area, 2021-2034
10.2.6. Europe Gene Therapy Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Gene Therapy Market revenue (US$ Million) By Type, 2021-2034
10.3.2. Asia Pacific Gene Therapy Market revenue (US$ Million) By Vector, 2021-2034
10.3.3. Asia Pacific Gene Therapy Market revenue (US$ Million) By Delivery method, 2021-2034
10.3.4. Asia Pacific Gene Therapy Market revenue (US$ Million) By Route of administration, 2021-2034
10.3.5. Asia Pacific Gene Therapy Market revenue (US$ Million) By Therapeutic Area, 2021-2034
10.3.6. Asia Pacific Gene Therapy Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Gene Therapy Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
10.4.2. Latin America Gene Therapy Market revenue (US$ Million) By Vector, (US$ Million) 2021-2034
10.4.3. Latin America Gene Therapy Market revenue (US$ Million) By Delivery method, (US$ Million) 2021-2034
10.4.4. Latin America Gene Therapy Market revenue (US$ Million) By Route of administration, (US$ Million) 2021-2034
10.4.5. Latin America Gene Therapy Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
10.4.6. Latin America Gene Therapy Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Gene Therapy Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
10.5.2. Middle East & Africa Gene Therapy Market revenue (US$ Million) By Vector, (US$ Million) 2021-2034
10.5.3. Middle East & Africa Gene Therapy Market revenue (US$ Million) By Delivery method, (US$ Million) 2021-2034
10.5.4. Middle East & Africa Gene Therapy Market revenue (US$ Million) By Route of administration, (US$ Million) 2021-2034
10.5.5. Middle East & Africa Gene Therapy Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
10.5.6. Middle East & Africa Gene Therapy Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Novartis AG (Switzerland),
11.2.2. Biogen Inc. (US),
11.2.3. Gilead Sciences, Inc. (US),
11.2.4. Bristol-Myers Squibb (US),
11.2.5. Alnylam Pharmaceuticals, Inc. (US),
11.2.6. Sarepta Therapeutics, Inc. (US)